These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

124 related articles for article (PubMed ID: 10829301)

  • 1. [What is the evidence with regard to the effectiveness of orlistat?].
    Nordmann A
    Schweiz Med Wochenschr; 2000 Apr; 130(17):629-34. PubMed ID: 10829301
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Pharmacological therapy of obesity].
    Pagotto U; Vanuzzo D; Vicennati V; Pasquali R
    G Ital Cardiol (Rome); 2008 Apr; 9(4 Suppl 1):83S-93S. PubMed ID: 18773755
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Orlistat: a review of its use in the management of obesity.
    Hvizdos KM; Markham A
    Drugs; 1999 Oct; 58(4):743-60. PubMed ID: 10551441
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Orlistat: current status in clinical therapeutics.
    McClendon KS; Riche DM; Uwaifo GI
    Expert Opin Drug Saf; 2009 Nov; 8(6):727-44. PubMed ID: 19998527
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Changes in body weight and serum lipid profile in obese patients treated with orlistat in addition to a hypocaloric diet: a systematic review of randomized clinical trials.
    Hutton B; Fergusson D
    Am J Clin Nutr; 2004 Dec; 80(6):1461-8. PubMed ID: 15585756
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Orlistat (Xenical)].
    Crenier L; Sternon J
    Rev Med Brux; 1999 Jun; 20(3):159-63. PubMed ID: 10429540
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The effects of orlistat on weight and on serum lipids in obese patients with hypercholesterolemia: a randomized, double-blind, placebo-controlled, multicentre study.
    Muls E; Kolanowski J; Scheen A; Van Gaal L;
    Int J Obes Relat Metab Disord; 2001 Nov; 25(11):1713-21. PubMed ID: 11753595
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effect of orlistat on weight and body composition in obese adolescents: a randomized controlled trial.
    Chanoine JP; Hampl S; Jensen C; Boldrin M; Hauptman J
    JAMA; 2005 Jun; 293(23):2873-83. PubMed ID: 15956632
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Cost-effectiveness of orlistat for the treatment of overweight and obese patients in Ireland.
    Lacey LA; Wolf A; O'shea D; Erny S; Ruof J
    Int J Obes (Lond); 2005 Aug; 29(8):975-82. PubMed ID: 15852050
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The cost effectiveness of orlistat in a 1-year weight-management programme for treating overweight and obese patients in Sweden : a treatment responder approach.
    Hertzman P
    Pharmacoeconomics; 2005; 23(10):1007-20. PubMed ID: 16235974
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Orlistat for the treatment of obesity: rapid review and cost-effectiveness model.
    Foxcroft DR; Milne R
    Obes Rev; 2000 Oct; 1(2):121-6. PubMed ID: 12119985
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Weight loss, weight maintenance, and improved cardiovascular risk factors after 2 years treatment with orlistat for obesity. European Orlistat Obesity Study Group.
    Rössner S; Sjöström L; Noack R; Meinders AE; Noseda G
    Obes Res; 2000 Jan; 8(1):49-61. PubMed ID: 10678259
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Randomized placebo-controlled trial of orlistat for weight loss and prevention of weight regain in obese patients].
    Sjostrom L; Rissanen A; Andersen T; Boldrin M; Golay A; Koppeschaar H; Krempf M;
    Ter Arkh; 2000; 72(8):50-4. PubMed ID: 11019429
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Orlistat: a review of its use in the management of patients with obesity.
    Curran MP; Scott LJ
    Drugs; 2004; 64(24):2845-64. PubMed ID: 15563254
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Orlistat in the treatment of obesity.
    Ballinger A
    Expert Opin Pharmacother; 2000 May; 1(4):841-7. PubMed ID: 11249520
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Orlistat.
    Wong NN; Cheng-Lai A
    Heart Dis; 2000; 2(2):174-81. PubMed ID: 11728255
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Review article: malnutrition and maltreatment--a comment on orlistat for the treatment of obesity.
    Cahill A; Lean ME
    Aliment Pharmacol Ther; 1999 Aug; 13(8):997-1002. PubMed ID: 10468673
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Orlistat: its current status as an anti-obesity drug.
    Ballinger A; Peikin SR
    Eur J Pharmacol; 2002 Apr; 440(2-3):109-17. PubMed ID: 12007529
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Spotlight on orlistat in the management of patients with obesity.
    Curran MP; Scott LJ
    Treat Endocrinol; 2005; 4(2):127-9. PubMed ID: 15783249
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Orlistat: a review of its use in the management of obesity.
    Henness S; Perry CM
    Drugs; 2006; 66(12):1625-56. PubMed ID: 16956313
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.